Drawing for SOPHOMER

USPTO serial 79370561

SOPHOMER

Reviewed by CopyMark Law Group

Reg. 7435617Status 700Registered
Filing date
Status date
Registration date
Jul 9, 2024
Examiner
WUDARSKY, MINDY CHEK
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SOPHOMER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical substances and chemical preparations for scientific purposes, other than for medical or veterinary use; ] chemical substances for analysis in laboratories, other than for medical or veterinary purposes; chemical compositions for use in science, other than for medical or veterinary use; chemicals for use in separation techniques, other than medical or veterinary, namely, oil separating chemicals; catalysts for chemical and biochemical processes; chemical reagents, other than for medical or veterinary purposes; industrial chemicals; particulate material for use in chromatographic processes other than for medical use, namely, chromatography separation media for separation of a mixture into components; diagnostic chemicals other than for medical or veterinary use; diagnostic preparations for scientific or research use; unprocessed synthetic polymers; diagnostic testing materials in the nature of paramagnetic particles, separation membranes, reagent bearing test strips, cell culture media supplements and reagents, other than for medical use; reagents for use in analytical tests, other than for medical or veterinary purposes; unprocessed polymers for use in the analysis of biochemicals; chemicals for use in immuno-assay testing, other than medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria, other than for medical or veterinary purposesACTIVE—
005Chemical test reagents for medical purposes; chemical reagents for medical use; diagnostic substances for medical use; diagnostic chemical reagents for medical use; chemical preparations for medical purposes, namely, for blocking of nonspecific interactions in the diagnostic assays; chemical substances for use in separation for medical and veterinary purposes; chemicals for use in chromatography for medical and veterinary purposes, namely, chromatography separation media for separation of a mixture into components; diagnostic testing materials in the nature of paramagnetic particles, separation membranes, medical diagnostic test stripsand reagents for medical use for blood, urine, and body fluids testing; in vitro diagnostic preparations for medical use; reagents for in-vitro laboratory use for medical purposes; immunoassay reagents for medical use; diagnostic preparations for medical purposesACTIVE—
010Medical apparatus and instruments, namely, multiwell plates, point of care instruments and in vitro diagnostics analyzers; medical apparatus for use in cellular analysis and diagnosis for testing of cellular biomarkers in blood, urine, body fluids, in vitro cultured cells; diagnostic apparatus for medical purposes for testing of biomarkers in blood, urine, and body fluids, cells and tissues; testing apparatus for medical purposes for testing of biomarkers in blood, urine, body fluids, cells and tissues; [ robotics for medical purposes, namely, surgical robots; ] medical apparatus for measuring and displaying data measured from bodily fluids, including accessories in the nature of tubes and systems for body fluids storage; blood testing apparatus; medical apparatus for measuring biochemical changes in the blood; tools for sample preparation for medical diagnostics testingACTIVE—
042Chemical analysis; life science research and development services; scientific research for medical purposes; pharmaceutical research; biological analysis; analytical medical laboratory services; analysis in the field of molecular biology; biochemistry research services; laboratory testing and contract assay development chemistry services; chemical research and analysis services; biological research; biological laboratory services; pharmaceutical, medical and dental laboratory services, namely, laboratory testing; design and development of medical diagnostic apparatus; [ medical consultancy in the fields of laboratory research, testing, measuring, and analysis; medical consultancy in the field of design and development of medical equipment; ] consultancy in the fields of medical measuring, testing and analysis; design and development of computer hardware and software for healthcare requirements; computer programming in the medical field; providing information on the subject of scientific research in the field of biochemistry and biotechnology; [ science and technology services, namely scientific research, analysis and testing in the fields of biochemistry and biotechnology; ] technological consultancy in the fields of biochemistry and biotechnology; [ scientific and ] technological services, namely, computer aided testing for others in the fields of biochemistry and biotechnology; [ medical laboratory services; ] none of the foregoing relating to the field of security or cybersecurity hardware, software or servicesACTIVE—
044Medical diagnostic services; medical services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 4, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 16, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 23, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 4, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jan 17, 2025LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Jan 16, 2025COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jan 16, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 20, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 30, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 27, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 25, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 3, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 3, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 21, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2023DOCKASSIGNED TO EXAMINER—
May 30, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
May 26, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 25, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance